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Research on the Development of the Manufacture of Medicine Based on
Gray Correlation Analysis：
Analysis of Yangtze River and Pearl River Deltas in China
Xiang Ying1一
1 School of Management, Zhejiang Chinese Medical University, China
Abstract: Giving the fact that manufacturing industry is still the engine of economic development in developing countries,
China pays special attention to the development of manufacturing industry, especially the hi-tech industry. This paper takes
the manufacture of medicine as an example, aiming to investigate the development status of the manufacture of medicine in
Yangtze River and Pearl River Deltas, which are China's major manufacturing centers. In this context, the dynamic index
system composed of R&D Stage, Production Stage and Output Stage is established and the Gray Correlation Analysis Model
is applied in evaluating. The results indicate that there is a gap between Yangtze River and Pearl River Deltas. The capacity
of turning R&D and innovation input into output is important to promote the development of the manufacture of medicine
and the synergy effect of the industry value chain can’t be ignored.
Keywords:Manufacture of Medicine, Development, Gray Correlation Analysis
1. INTRODUCTION
Economists have for a long time discussed the causes of economic growth and the mechanisms behind it.
According to Kaldor (1966) [1], an important stylized fact in the growth trajectory of developed economies in the
postwar period is the relationship between industrial growth and the performance of the economy as a
whole.(Gilberto Libanio, 2005)[2] Even in recent years, a large number of empirical studies confirmed the
“manufacturing is the engine of growth” hypothesis both in developed countries and developing countries.
[3][4][5]The dynamic forces of globalization and the emergence of the knowledge based economy have made the
manufacturing industry, especially the hi-tech industry the leading sector and the engine of growth. Taking the
manufacture of medicine as an example, it has been one of the top three industries in developed countries such
as the USA and Japan. The manufacture of medicine got the highest margin (17.2%) of all the industries,
significantly higher than the telecommunication industry (8.1%) and computer industry (7.3%).[6] Some
developing countries also realize the importance of hi-tech industries and set up strategies to promote the
development of hi-tech industries. For example, the manufacture of medicine belongs to China’s one of nine
strategic emerging industries, which are proposed in 2009.
The Yangtze River Delta (YRD) and the Pearl River Delta (PRD) in China are two of the most dynamic
manufacturing regions. The YRD mainly includes Shanghai, Jiangsu Province and Zhejiang Province while the
PRD mainly includes Guangzhou, Shenzhen and Zhuhai. This paper aims at investigating the development
status of the manufacture of medicine between the YRD and the PRD.
The rest of the study is organized as follows: the index based on value chain network is set about in Section
2. Section 3 set about evaluation using Grey Correlation Analysis followed by this study while in section 4
empirical findings are provided. Section 5 concludes the articles.
一 Corresponding author. Email: yingxiang0571@homail.com, yingxiang0571@126.com(China)
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2. INDEX SYSTEM OF THE DEVELOPMENT OFTHE MANUFACTURE OFMEDICINE
According to the Value chain, originally proposed by Michael Porter[7] in 1985, the article has established
an evaluate index system of the Development of the Manufacture of Medicine. Porter believes that the
enterprises’ value creation process can be divided into several parts: design, production, distribution, delivery
and those different but interrelated supporting economic activities. According to the characteristics of value
chain, the index system is composed of R&D Stage, Production Stage and Output Stage based on the science
and the reality principle, the systematic principle, the comparable principle, the operational principle and the
dynamic principle of continuity. (As shown in table 1)
Table 1. The index system
First grade Index Second grade Index Description of Second grade Index
R&D Stage
Number of R&D Personnel R&D Scale in R&D Stage
R&D Internal Expenditure R&D Investment in R&D Stage
Number of New Products Effects of R&D in R&D Stage
Production Stage
Fixed Asset Investment by year end Asset Size in Production Stage
New Fixed Asset Value Asset Investment in Production Stage
Average Number of Employees Employment Scale in Production Stage
Output Stage
Market Share Market Share in Output Stage
Total Profit Level of Profitability in Output Stage
Export delivery value Export Scale in Output Stage
Total Output Sales Volume in Output Stage
Note: Market Share=Local Sales Revenue/ State Sales Revenue
In this study, the manufacture of medicine is classified based on the state’s Statistics Catalogue of
High-technology Industry Classifications (Version 2002). Table below shows the sector group numbers for
related sectors that were taken into account for analysis. The indices mentioned above were used to compare the
Yangtze River Delta (YRD) and the Pearl River Delta (PRD)’s development status in the manufacture of
medicine.
Table 2. The catalogue of Manufacture of Medicine
NO. Name Code
1 Manufacture of Medicine 27
2 Manufacture of Chemical Medicine 2710+2720
3 Manufacture of Finished Traditional Chinese Herbal Medicine 2730+2740
4 Manufacture of Biological and Biochemical Chemical Products 2760
3. GRAYCORRELATIONANALYSIS MODEL
The basic concept of grey correlation analysis is to determine whether a relationship among a series of data
is close, based on the degree of similarity among the geometric shapes of the data series’ curves.[8][9][10] When
the method of grey correlation analysis was first proposed by Deng(1982), it has been used by hundreds of
experts in many research fields. The strength of grey correlation is that it can improve the accuracy of modeling,
decision-making and control systems, especially those systems which have incomplete information and unclear
operating mechanism.
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3.1 Selection of optimal value
Assume i as the serial number of the i-th evaluation unit, i＝1，2，…，m；k as the index number of the k-th
evaluation indicator, k＝1，2，…，n, vik as the evaluation value. Select v0k ＝Optimum(vik)，where k＝1，2，…n,
V0k= (v01 ,v02 ,…, v0n ) (1)
Get the candidate region m valuate matrix V with evaluation indicator n.
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3.2 Standardization of the index value
Dimensionless is important for us to compare the various index value for each indicator, the formula is
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3.3 Calculate the grey relational coefficient
Use X0=(x01 , x02 ,…, x0n ) as the reference series and
Xi= (xi1 , xi2… xin ) (n=1,2…n) as the comparison series, we can calculate the grey relational coefficient,
that is:
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i=1,2,…,m k=1,2,…,n
where  =0.5,  [0,1]
Then we can get the relational matrix E
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3.4 Calculate the grey relational degree
Take the weight of the second grade index as wk=0.1, k=1,2,…10, and the weight of the first grade index
as wk’=1/3, k’=1,2,3, we can calculate the grey relational degree, the formula is
T
mmi WErrrrR   ),,()( 211  (6)
4. EMPIRICAL FINDINGSWHAT
This section is to measure the correlations of the Manufacture of Medicine for Yangtze River and Pearl
River Deltas in mainland China, date are from latest China High-tech Industry Statistics Yearbook 2012.
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In order to select the relative optimal value more accurately, we calculated the grey relational coefficient of
31 economic zones in mainland China first as follows: First, select the relative optimal value as the optimal
reference vector use formula 1 V0k =(9019，206358，201，1018，142，183720，20.323，184，215，1616).
Then, Calculate the grey relational coefficient by formula from 2 to 5 sik ( i =1,2… m k=1,2…n) . Table 3 shows
the grey relational coefficient of 31 economic zones in mainland China. After that, we calculate the grey
relational degree of the Manufacture of Medicine for Yangtze River and Pearl River Deltas by formula 6.
Figure1 below shows the grey relational coefficient of the second grade index of the Manufacture of
Medicine for Yangtze River and Pearl River Deltas in mainland China. And Table 4 shows the grey relational
degree of the first grade index.
The results indicate that Yangtze River Delta has a comparative advantage in R&D Stage and Production
Stage as well as Output Stage. Because of the locational advantages, Pearl River Deltas used to be the frontier of
undertaking industrial transfer from Taiwan. But now Manufacture of Medicine develops faster in Yangtze River
Delta as the talent aggregation and the FDI investment, especially in Shanghai and Jiangsu. Therefore R&D
stage is one of the important factors influencing the development of industries,( Lan et al. 2008)[12] The score of
R&D stage is 0.688 in Yangtze River Delta and 0.647 in Pearl River Delta respectively.
However, of all the three stages, Output Stage owns the highest score both in Yangtze River and Pearl
River Deltas. The grey relational degree was found to be greater than 0.8, which reveals that it is particularly
important to turn R&D and innovation input into practical output.[13]
Figure 1. The grey relational coefficient for the third index (Si)
Table 4. The grey relational degree for the third index
Yangtze River Delta Pearl River Delta
R&D Stage 0.688 0.647
Production Stage 0.501 0.429
Output Stage 0.805 0.624
The grey relational coefficient in figure 1 also indicates that synergy of all aspects in the industry value
chain can’t be ignored. Synergy can create effect within industry cluster to gain stronger profitability than single
enterprise. That is”1+1>2” effect. [14]Thus competitive advantage can be achieved and sustained. Five out of ten
grey relational coefficients in Pearl River Delta are below 0.5, while the grey relational coefficients of Fixed
Asset Investment by year end and New Fixed Asset Value are below 0.4.
Table 3. The gray relational coefficient Sik in manufacture of medicine for 31 provinces in China
si1 s i2 s i3 s i4 s i5 si6 s i7 s i8 s i9 s i10
Beijing 0.4132 0.3704 0.5051 0.3472 0.3425 0.4132 0.3817 0.4202 0.3401 0.3937
Tianjin 0.4000 0.3968 0.4950 0.3876 0.3571 0.3937 0.3846 0.3876 0.3650 0.3788
Hebei 0.5155* 0.4237 0.5319* 0.5263* 0.5102* 0.4717 0.3704 0.4167 0.4348 0.4132
Shanxi 0.3597 0.3448 0.3472 0.3650 0.3497 0.3759 0.3356 0.3448 0.3378 0.3472
Inner Mongolia 0.3401 0.3378 0.3401 0.3817 0.3546 0.3623 0.3333 0.3676 0.3401 0.3597
Liaoning 0.3846 0.3597 0.3876 0.6098** 0.4348 0.4032 0.3448 0.3817 0.3571 0.3968
Jilin 0.3650 0.3448 0.3759 0.8929** 1.0000** 0.4673 0.3497 0.4032 0.3378 0.4425
Heilongjiang 0.4098 0.3817 0.4274 0.4202 0.4310 0.4000 0.3425 0.3906 0.3425 0.3676
Shanghai 0.4098 0.4310 0.4545 0.3497 0.3597 0.4167 0.4000 0.4202 0.3731 0.4000
Jiangsu 0.9091** 1.0000** 1.00** 0.6173** 0.5556* 0.8197** 1.0000** 0.7143** 0.6329** 0.8065**
Zhejiang 0.7692** 0.5618* 0.6579** 0.3968 0.3937 0.6024** 0.5102* 0.5000* 1.000** 0.4854
Anhui 0.3788 0.3597 0.3817 0.4505 0.4032 0.4098 0.3521 0.3597 0.3472 0.3704
Fujian 0.3571 0.3546 0.3906 0.3623 0.3497 0.3623 0.3472 0.3546 0.3546 0.3546
Jiangxi 0.3788 0.3623 0.4000 0.6579** 0.6329** 0.4630 0.3597 0.3788 0.3497 0.4132
Shandong 1.00** 0.9804** 0.9804** 1.00** 0.7143** 1.00** 0.7143** 1.00** 0.6173** 1.00**
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Henan 0.4505 0.3817 0.4348 0.7937** 0.6329** 0.5618* 0.3876 0.4902 0.3497 0.4808
Hubei 0.4310 0.3704 0.4673 0.5263* 0.5747* 0.4545 0.4065 0.3906 0.3817 0.4000
Hunan 0.3788 0.3650 0.3817 0.4348 0.4032 0.4202 0.3546 0.3846 0.3401 0.3937
Guangdong 0.6173** 0.5050* 0.8197** 0.3846 0.3650 0.5376* 0.4237 0.5263* 0.4274 0.4951
Guangxi 0.3546 0.3425 0.3759 0.3817 0.3704 0.3846 0.3448 0.3650 0.3378 0.3571
Hainan 0.3401 0.3401 0.3650 0.3333 0.3333 0.3448 0.3333 0.3497 0.3333 0.3425
Chongqing 0.3817 0.3650 0.4505 0.3846 0.3650 0.3759 0.3650 0.3497 0.3497 0.3597
Sichuan 0.3571 0.3546 0.3546 0.4630 0.4545 0.5208* 0.3597 0.4310 0.3650 0.4464
Guizhou 0.3497 0.3425 0.3846 0.3425 0.3356 0.3650 0.3425 0.3571 0.3333 0.3597
Yunnan 0.3597 0.3472 0.3472 0.3546 0.3472 0.3597 0.3448 0.3546 0.3356 0.3521
Tibet 0.3333 0.3333 0.3333 0.3333 0.3333 0.3333 0.3333 0.3356 0.3333 0.3333
Shaanxi 0.3817 0.3497 0.3521 0.3731 0.3650 0.3846 0.3425 0.3571 0.3356 0.3676
Gansu 0.3425 0.3546 0.3401 0.3497 0.3472 0.3472 0.3356 0.3425 0.3333 0.3401
Qinghai 0.3333 0.3333 0.3356 0.3356 0.3356 0.3378 0.3333 0.3333 0.3333 0.3356
Ningxia 0.3448 0.3401 0.3448 0.3356 0.3333 0.3378 0.3448 0.3378 0.3425 0.3356
Xinjiang 0.3333 0.3333 0.3333 0.3356 0.3356 0.3356 0.3333 0.3333 0.3333 0.3333
Note: “**”means S ik＞0.6; “*”means 0.5＜ S ik ＜0.
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5. CONCLUSIONS
This study was conducted by focusing on development of the Manufacture of Medicine for Yangtze River
and Pearl River Deltas in mainland China. The empirical studies show that there is a competitiveness gap
between Yangtze River and Pearl River Deltas. There is a comparative advantage of the Manufacture of
Medicine in Yangtze River Delta. Although the development of the Manufacture of Medicine as well as the
other hi-tech industries could not leave without R&D input and innovation, it is more important to turn R&D
and innovation input into practical output. Also, the synergy effect of the industry value chain can’t be ignored.
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